Price Discrimination in Practice: The Market for Drugs in Egypt and the U.S
Rania Zaher Naguib ()
Additional contact information
Rania Zaher Naguib: Faculty of Management Technology, The German University in Cairo
No 20, Working Papers from The German University in Cairo, Faculty of Management Technology
This paper attempts to analyze the medical and economical reasons that cause a difference in the price elasticity of patients' demand to drugs between Egypt and the United States of America. The study was based on two medicines produced by Pfizer (Lipitor and Viagra), with both of them available in Egypt as well as the United States. The result of this study reflected that Egyptians are more sensitive to the changes in price relative to Americans for both Lipitor and Viagra because of different economical and medical factors.
Keywords: Price Discrimination; Pharmaceutical Industry (search for similar items in EconPapers)
JEL-codes: D42 I11 (search for similar items in EconPapers)
Pages: 20 pages
New Economics Papers: this item is included in nep-ara, nep-com, nep-ind and nep-mkt
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
http://mgt.guc.edu.eg/wpapers/020zaher2010.pdf First version, 2010 (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:guc:wpaper:20
Access Statistics for this paper
More papers in Working Papers from The German University in Cairo, Faculty of Management Technology Contact information at EDIRC.
Bibliographic data for series maintained by Lobna Sameer ( this e-mail address is bad, please contact ).